Blog: MS news

Ocrelizumab licensed for people with early primary progressive MS in the UK

22 January 2018

Source MS Society:

Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.

Urine infections in MS – an integrated approach to prevention & treatment.

3 January 2018

Source Miranda's MS Blog:

Miranda is an MS Specialist Nurse based in Bedford, she writes a blog to share things she has found good, useful or positive within the MS community.

Veterinary Nurse with MS loses case for more help

3 January 2018

Source ITV Meridian News:

Multiple Sclerosis is a condition that affects more than 1100,000 people in the UK but the MS Society claims that it's becoming more difficult for sufferers to claim disability benefit.

The charity is highlighting the case of a trainee veterinary nurse from Dorset who's been turned down for extra cash under the new Personal Independence payment system. Richard Slee also talked to Genevieve Edwards of the MS Society....

Today is Festival of Sleep Day!

3 January 2018

Source MS Trust:

As today is Festival of Sleep Day, we're talking sleep and MS. Poor sleep is common in people with multiple sclerosis, with about 50% of people reported to experience some form of sleep disturbance.

Special Christmas Shopping Event in Reading

23 November 2017

Source Reading Borough Council

Once again, Reading Borough Council are hosting a Special Shopping Evening for older and those with disabilities.

Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports

23 November 2017

Source Multiple Sclerosis News Today:

Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a).

These results will be used to support a request for ozanimod’s approval as an MS therapy with the U.S. Food and Drug Administration (FDA), a filing known as a New Drug...

The Search for a Miracle Cure - Channel 4, 23rd November at 10pm

23 November 2017

Source Radio Times:

Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his high-profile battle with the tabloids has exacerbated his symptoms. Now 50, he travels to Hadassah University Medical Centre in Jerusalem, where the work being done could have a positive impact on...

Targeting Blood-clotting Protein Can Restore Brain’s Potential to Repair Myelin Layer, Study Shows

8 November 2017

Source Multiple Sclerosis News Today:

A blood-clotting protein called fibrinogen prevents myelin production and blocks the neuron remyelination repair process in mice, a study finds.

Cladribine: new oral treatment to be available for people with relapsing MS

8 November 2017

Source MS Society:

A new oral treatment for relapsing MS, called cladribine, will be made available on the NHS in England and Wales within the next three months.

Diagnostic Blood Test May Be Able to Distinguish Between RRMS and PPMS, Researchers Say

8 November 2017

Source Mutiple Sclerosis News Today:

In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.

Pages

Category

Archive